Appay R, Dehais C, Maurage CA, Alentorn A, Carpentier C, Colin C, Ducray F, Escande F, Idbaih A, Kamoun A et al (2019) CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas. Neuro Oncol 21:1519–1528. https://doi.org/10.1093/neuonc/noz124

Article  CAS  Google Scholar 

Bady P, Delorenzi M, Hegi ME (2016) Sensitivity analysis of the MGMT-STP27 model and impact of genetic and epigenetic context to predict the MGMT methylation status in gliomas and other tumors. J Mol Diagn 18:350–361. https://doi.org/10.1016/j.jmoldx.2015.11.009

Article  CAS  Google Scholar 

Bady P, Sciuscio D, Diserens A-C, Bloch J, den Bent M, Marosi C, Dietrich P-Y, Weller M, Mariani L, Heppner F et al (2012) MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status. Acta Neuropathol 124:547–560. https://doi.org/10.1007/s00401-012-1016-2

Article  CAS  Google Scholar 

Baylin SB, Jones PA (2016) Epigenetic determinants of cancer. Cold Spring Harb Perspect Biol. https://doi.org/10.1101/cshperspect.a019505

Article  Google Scholar 

Capper D, Jones D, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss D et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469–474. https://doi.org/10.1038/nature26000

Article  CAS  Google Scholar 

Capper D, Stichel D, Sahm F, Jones D, Schrimpf D, Sill M, Schmid S, Hovestadt V, Reuss D, Koelsche C et al (2018) Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol 136:181–210. https://doi.org/10.1007/s00401-018-1879-y

Article  CAS  Google Scholar 

Ceccarelli M, Barthel F, Malta T, Sabedot T, Salama S, Murray B, Morozova O, Newton Y, Radenbaugh A, Pagnotta S et al (2016) Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell 164:550–563. https://doi.org/10.1016/j.cell.2015.12.028

Article  CAS  Google Scholar 

Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, Sabedot TS, Malta TM, Pagnotta SM, Castiglioni I et al (2016) TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res 44:e71. https://doi.org/10.1093/nar/gkv1507

Article  CAS  Google Scholar 

de Souza C, Sabedot T, Malta T, Stetson L, Morozova O, Sokolov A, Laird P, Wiznerowicz M, Iavarone A, Snyder J et al (2018) A distinct DNA methylation shift in a subset of glioma CpG island methylator phenotypes during tumor recurrence. Cell Rep 23:637–651. https://doi.org/10.1016/j.celrep.2018.03.107

Article  CAS  Google Scholar 

Ferreyra Vega S, Olsson Bontell T, Corell A, Smits A, Jakola A, Caren H (2021) DNA methylation profiling for molecular classification of adult diffuse lower-grade gliomas. Clin Epigenetics 13:102. https://doi.org/10.1186/s13148-021-01085-7

Article  CAS  Google Scholar 

Ferreyra Vega S, Wenger A, Kling T, Olsson Bontell T, Jakola AS, Caren H (2022) Spatial heterogeneity in DNA methylation and chromosomal alterations in diffuse gliomas and meningiomas. Mod Pathol. https://doi.org/10.1038/s41379-022-01113-8

Article  Google Scholar 

Hovestadt V, Zapatka M (2015) conumee: enhanced copy-number variation analysis using Illumina 450k methylation arrays. R package version 1.9.0. http://bioconductor.org/packages/conumee/.

Jones P, Issa J, Baylin S (2016) Targeting the cancer epigenome for therapy. Nat Rev Genet 17:630–641. https://doi.org/10.1038/nrg.2016.93

Article  CAS  Google Scholar 

Kassambara A, Kosinski M, Biecek P, Fabian S (2021) survminer: drawing survival curves using ‘ggplot2’ https://cran.r-project.org/web/packages/survminer/index.html. Accessed 20230113 2023

Louis D, Perry A, Reifenberger G, Deimling A, Figarella-Branger D, Cavenee W, Ohgaki H, Wiestler O, Kleihues P, Ellison D (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1

Article  Google Scholar 

Louis D, Perry A, Wesseling P, Brat D, Cree I, Figarella-Branger D, Hawkins C, Ng H, Pfister S, Reifenberger G et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231–1251. https://doi.org/10.1093/neuonc/noab106

Article  CAS  Google Scholar 

Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109. https://doi.org/10.1007/s00401-007-0243-4

Article  Google Scholar 

Maksimovic J, Oshlack A, Phipson B (2021) Gene set enrichment analysis for genome-wide DNA methylation data. Genome Biol 22:173. https://doi.org/10.1186/s13059-021-02388-x

Article  CAS  Google Scholar 

Molecular neuropathology (2022) Brain classifier 12.5 https://www.molecularneuropathology.org/mnp

Morris TJ, Butcher LM, Feber A, Teschendorff AE, Chakravarthy AR, Wojdacz TK, Beck S (2014) ChAMP: 450k chip analysis methylation pipeline. Bioinformatics 30:428–430. https://doi.org/10.1093/bioinformatics/btt684

Article  CAS  Google Scholar 

Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, Pan F, Pelloski CE, Sulman EP, Bhat KP et al (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17:510–522. https://doi.org/10.1016/j.ccr.2010.03.017

Article  CAS  Google Scholar 

Ostrom Q, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan J (2020) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro Oncol 22:iv1–iv96. https://doi.org/10.1093/neuonc/noaa200

Article  Google Scholar 

Ostrom QT, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2021) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014–2018. Neuro Oncol 23:iii1–iii105. https://doi.org/10.1093/neuonc/noab200

Article  Google Scholar 

Patel A, Tirosh I, Trombetta J, Shalek A, Gillespie S, Wakimoto H, Cahill D, Nahed B, Curry W, Martuza R et al (2014) Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344:1396–1401. https://doi.org/10.1126/science.1254257

Article  CAS  Google Scholar 

Qin Y, Feng H, Chen M, Wu H, Zheng X (2018) InfiniumPurify: an R package for estimating and accounting for tumor purity in cancer methylation research. Genes Dis 5:43–45. https://doi.org/10.1016/j.gendis.2018.02.003

Article  CAS  Google Scholar 

R CoreTeam (2021) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria https://www.R-project.org/

Rodriguez FJ, Scheithauer BW, Jenkins R, Burger PC, Rudzinskiy P, Vlodavsky E, Schooley A, Landolfi J (2007) Gliosarcoma arising in oligodendroglial tumors (“oligosarcoma”): a clinicopathologic study. Am J Surg Pathol 31:351–362. https://doi.org/10.1097/01.pas.0000213378.94547.ae

Article  Google Scholar 

Shirahata M, Ono T, Stichel D, Schrimpf D, Reuss D, Sahm F, Koelsche C, Wefers A, Reinhardt A, Huang K et al (2018) Novel, improved grading system(s) for IDH-mutant astrocytic gliomas. Acta Neuropathol 136:153–166. https://doi.org/10.1007/s00401-018-1849-4

Article  CAS  Google Scholar 

Sottoriva A, Spiteri I, Piccirillo S, Touloumis A, Collins V, Marioni J, Curtis C, Watts C, Tavare S (2013) Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci U S A 110:4009–4014. https://doi.org/10.1073/pnas.1219747110

Article  Google Scholar 

Suwala AK, Felix M, Friedel D, Stichel D, Schrimpf D, Hinz F, Hewer E, Schweizer L, Dohmen H, Pohl U et al (2022) Oligosarcomas, IDH-mutant are distinct and aggressive. Acta Neuropathol 143:263–281. https://doi.org/10.1007/s00401-021-02395-z

Article  CAS  Google Scholar 

The Cancer Genome Atlas Research Network (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481–2498

Article  Google Scholar 

Therneau T (2022) A package for survival analysis in R. R package version 3.4-0. https://CRAN.R-project.org/package=survival

Tian Y, Morris TJ, Webster AP, Yang Z, Beck S, Feber A, Teschendorff AE (2017) ChAMP: updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics 33:3982–3984. https://doi.org/10.1093/bioinformatics/btx513

Article  CAS  Google Scholar 

Turcan S, Rohle D, Goenka A, Walsh LA, Fang F, Yilmaz E, Campos C, Fabius AW, Lu C, Ward PS et al (2012) IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483:479–483. https://doi.org/10.1038/nature10866

Article  CAS  Google Scholar 

Vajtai I, Vassella E, Hewer E, Kappeler A, Reinert MM (2012) Sarcomatous evolution of oligodendroglioma (“oligosarcoma”): confirmatory report of an uncommon pattern of malignant progression in oligodendroglial tumors. Pathol Res Pract 208:750–755. https://doi.org/10.1016/j.prp.2012.09.009

Article  Google Scholar 

Wei T, Simo V (2021) R package ‘corrplot’: visualization of a correlation matrix. R package version 0.92. https://github.com/taiyun/corrplot

Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn J, Minniti G, Bendszus M, Balana C, Chinot O, Dirven L et al (2021) EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol 18:170–186. https://doi.org/10.1038/s41571-020-00447-z

Article  Google Scholar 

Wenger A, Ferreyra Vega S, Kling T, Olsson Bontell T, Jakola AS, Carén H (2019) Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification. Neuro Oncol 21:616–627. https://doi.org/10.1093/neuonc/noz011

Article  CAS  Google Scholar 

Wenger A, Ferreyra Vega S, Schepke E, Lofgren M, Olsson Bontell T, Tisell M, Nilsson D, Kling T, Caren H (2022) DNA methylation alterations across time and space in paediatric brain tumours. Acta Neuropathol Commun 10:105. https://doi.org/10.1186/s40478-022-01406-8

Article  CAS  Google Scholar 

WHO Classification of Tumours Editorial Board (2021) World Health Organization classification of tumours of the central nervous system, vol 6, 5th edn. Lyon

Yan H, Parsons D, Jin G, McLendon R, Rasheed B, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins G et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765–773. https://doi.org/10.1056/NEJMoa0808710

Article  CAS  Google Scholar 

Yasuda T, Nitta M, Komori T, Kobayashi T, Masui K, Maruyama T, Sawada T, Muragaki Y, Kawamata T (2018) Gliosarcoma arising from oligodendroglioma, IDH mutant and 1p/19q codeleted. Neuropathology 38:41–46. https://doi.org/10.1111/neup.12406

Article  CAS  Google Scholar